detomidine,
detomidine hydrochloride,
detomidine monohydrochloride,
DETOMIDINE HYDROCHLORIDE,
90038-01-0,
Detomidine HCl,
Domosedan,
MPV-253 AII,
Detomidine (hydrochloride),
UNII-95K4LKB6QE,
Detomidine hydrochloride [USAN],
95K4LKB6QE,
4-(2',3'-Dimethylbenzyl)imidazole hydrochloride,
4-(2,3-Dimethylbenzyl)imidazole monohydrochloride,
4-(2,3-dimethylbenzyl)-1h-imidazole hydrochloride,
4-((2,3-Dimethylphenyl)methyl)-1H-imidazole hydrochloride,
1H-Imidazole, 4-[(2,3-dimethylphenyl)methyl]-, monohydrochloride,
5-(2,3-Dimethylbenzyl)imidazole Hydrochloride,
DSSTox_CID_28587,
DSSTox_RID_82858,
DSSTox_GSID_48661,
5-(2,3-Dimethylbenzyl)-1H-imidazole Hydrochloride,
Detomidine hydrochloride (USAN),
5-[(2,3-dimethylphenyl)methyl]-1H-imidazole hydrochloride,
1H-Imidazole, 4-((2,3-dimethylphenyl)methyl)-, monohydrochloride,
CAS-90038-01-0,
NCGC00182057-02,
4-[(2,3-dimethylphenyl)methyl]-1H-imidazole;hydrochloride,
Dormosedan,
detomidine-hcl,
4-[(2,3-dimethylphenyl)methyl]-3H-imidazole hydrochloride,
detomidine monohydrochloride,
AC1L1K9L,
C12H14N2.HCl,
SCHEMBL203174,
CHEMBL2106210,
DTXSID7048661,
CTK8E7446,
HY-B0163A,
OIWRDXKNDCJZSM-UHFFFAOYSA-N,
BCP06805,
KS-00000G0E,
Tox21_113020,
AC-309,
MFCD17292784,
s2092,
AKOS024464193,
AKOS025149295,
Tox21_113020_1,
AS-2744,
CS-1996,
NCGC00182057-03,
4CA-0451,
AK160349,
AN-15972,
BC678002,
LS-78523,
O376,
SY046831,
AB1011444,
TX-012303,
D4331,
FT-0666296,
ST24046430,
SW219456-1,
4-(2,3-dimethylbenzyl)imidazol hydrochloride,
MFCD17292784 (97%),
D03702,
4-[(2,3-dimethylbenzyl)]imidazole hydrochloride,
038D010,
4-(2,3-DIMETHYLBENZYL)-1H-IMIDAZOLE HCL,
5-[(2,3-Dimethylphenyl)methyl]-1h-imidazole hcl,
J-516575,
4-(2,3-Dimethylbenzyl)-1H-imidazole hydrochloride (1:1),
5-[(2,3-dimethylphenyl)methyl]-1H-imidazole;hydrochloride,
4-[(2,3-Dimethylphenyl)methyl]-1H-imidazole monohydrochloride,
DETOMIDINE,
C12H15ClN2,
C12-H14-N2.Cl-H,
CID56031,
B1356,
A10298,
Detomidine hydrochloride, 99% - 250MG 250mg,